Northern Trust Corp Adial Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	N/A	406 Added 1.39%	29,705 $40,000
Q3 2021 Nov 15, 2021	BUY	N/A	7,426 Added 33.95%	29,299 $126,000
Q2 2021 Aug 13, 2021	BUY	N/A	21,873 New	21,873 $56,000
Q4 2020 Feb 11, 2021	SELL	N/A	-11,974 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	N/A	11,974 New	11,974 $27,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $29.8M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.